GSA Capital Partners »

Viking Therapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.3M 68k 18.61
2023-09-30 $993k 90k 11.07
2023-06-30 $979k 60k 16.20
2023-03-31 $1.9M 116k 16.65
2022-12-31 $2.0M 216k 9.40
2022-09-30 $602k 222k 2.72
2022-06-30 $484k 167k 2.89
2022-03-31 $419k 140k 3.00
2021-12-31 $353k 77k 4.60
2021-09-30 $336k 54k 6.27
2021-06-30 $203k 34k 5.98
2021-03-31 $377k 60k 6.32
2020-12-31 $412k 73k 5.64
2020-09-30 $63k 11k 5.78
2018-12-31 $103k 14k 7.63
2018-09-30 $368k 21k 17.44
2018-06-30 $534k 56k 9.48